Elevance Health 3Q 2025 Earnings Presentation

The provided text consists of excerpts from an Elevance Health 3Q 2025 Earnings Presentation, detailing the company's financial results and future outlook. Key highlights include the $6.03 adjusted diluted earnings per share for the third quarter and the reaffirmed full-year guidance of approximately $30.00. The presentation offers a look at 2026 considerations, emphasizing growth in the Carelon segment, improved Medicare Advantage Star ratings, and increased investments in AI and digital strategy. Financial data is presented across Elevance Health's segments—Health Benefits and Carelon—showing metrics such as operating revenue, operating gain, and margins for the third quarter of 2025 versus 2024. The overall strategic focus is presented as establishing Elevance Health as a lifetime health partner, aiming for at least 12% average annual growth in Adjusted Diluted Earnings Per Share over the long term.

There are no comments yet.

Please log in to write the first comment.